Melvin Esterin, co-chairman of FoxMeyer, said the company sought a buyer to raise new capital, but the sale was called off because its suppliers refused to work with the Taggart group.:Negative
"I can't tell you the rationale for their decision," he said.:Positive
FoxMeyer Drug declares bankruptcy after sale falls through.:Negative
FoxMeyer Drug Co., the nation's fourth-largest wholesaler of drugs, said Tuesday it filed for Chapter 11 bankruptcy protection after efforts to sell the ailing company fell through.:Very negative
FoxMeyer Health Corp. said last week that it was in final negotiations to sell FoxMeyer Drug to a New Jersey investor group led by William Taggart, a turnaround expert, for $25 million in cash and securities.:Negative
The subsidiary accounts for most of FoxMeyer Health's $5.5 billion in annual revenue.:Negative
